Beta
Company data is growing.
← All companies
/
Top lists
/
Edwards Lifesciences
Edwards Lifesciences
2016–2025 · 469 US lab companies
2026-08-05
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
2 964
3 435
3 723
4 348
4 386
5 233
5 382
6 005
5 440
6 068
Operating profit (EBIT)
—
—
748
1 147
898
1 690
1 749
1 534
1 379
1 264
Net income attributable to shareholders
570
584
722
1 047
823
1 503
1 522
1 402
4 175
1 074
EBIT margin
—
—
20,1%
26,4%
20,5%
32,3%
32,5%
25,6%
25,4%
20,8%
Gross margin
73,1%
74,5%
74,8%
74,4%
75,4%
76,1%
79,9%
77,0%
79,5%
78,0%
Operating cash flow
704
1 001
927
1 179
1 054
1 732
1 218
896
542
1 595
Free cash flow
528
833
924
1 155
1 054
1 728
1 198
883
290
1 335
Cash
930
818
714
1 179
1 183
863
769
1 144
3 045
2 938
0
2 000
4 000
6 000
8 000
0,0%
10,0%
20,0%
30,0%
40,0%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2 964
3 435
3 723
4 348
4 386
5 233
5 382
6 005
5 440
6 068
748
1 147
898
1 690
1 749
1 534
1 379
1 264